Colleen Oliver

438 total citations
21 papers, 269 citations indexed

About

Colleen Oliver is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Colleen Oliver has authored 21 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Colleen Oliver's work include Infant Nutrition and Health (4 papers), Nuclear Structure and Function (4 papers) and Bone Tissue Engineering Materials (3 papers). Colleen Oliver is often cited by papers focused on Infant Nutrition and Health (4 papers), Nuclear Structure and Function (4 papers) and Bone Tissue Engineering Materials (3 papers). Colleen Oliver collaborates with scholars based in United States, Australia and New Zealand. Colleen Oliver's co-authors include Helen Watson, Scott D. Boden, Louisa Titus, Gregory A. Hair, Manjula Viggeswarapu, Akihito Minamide, Barbara E. Cormack, Jane M. Alsweiler, Anna C. Tottman and Sreedhara Sangadala and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Colleen Oliver

21 papers receiving 264 citations

Peers

Countries citing papers authored by Colleen Oliver

Since Specialization

Citations

This map shows the geographic impact of Colleen Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Oliver more than expected).

Fields of papers citing papers by Colleen Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Oliver. The network helps show where Colleen Oliver may publish in the future.

Co-authorship network of co-authors of Colleen Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Oliver. A scholar is included among the top collaborators of Colleen Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Oliver. Colleen Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Local FK506 delivery induces osteogenesis in rat bone defect and rabbit spine fusion models 2024 ·Bone ·(unknown), (unknown), Sreedhara Sangadala, Jarred Kaiser, (unknown), Colleen Oliver, Steven M. Presciutti, Scott D. Boden, Nick J. Willett	2
2	A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799933 (ARRY-440) as a single agent and in combination therapy in participants 16 years and older with advanced solid tumors with BRAF alterations. 2023 ·Journal of Clinical Oncology ·J. Thaddeus Beck, Meredith McKean, Shirish M. Gadgeel, Daniel W. Bowles, Rizwan Haq, Rona Yaeger, Matthew H. Taylor, (unknown), (unknown), Colleen Oliver, A M Huelskamp, Gang Feng, Keren Sturtz	6
3	Long-Term Effectiveness of ARRY-371797 in People With Dilated Cardiomyopathy and a Faulty LMNA Gene: A Plain Language Summary 2023 ·Future Cardiology ·Daniel P. Judge, Matthew R.G. Taylor, Hui‐Hua Li, Colleen Oliver, Franca S. Angeli, Patrice A. Lee, Calum A. MacRae	2
4	A first-in-human, phase 1 study of the SHP2 inhibitor PF-07284892 as monotherapy and in combination with different targeted therapies in oncogene-driven, treatment-resistant solid tumors. 2023 ·Journal of Clinical Oncology ·Alexander Drilon, Melissa L. Johnson, Shirish M. Gadgeel, (unknown), Gang Feng, (unknown), Micaela B. Reddy, Allison S. Harney, Colleen Oliver, Bethany Mills, (unknown), S. Michael Rothenberg, Manish Sharma, Timothy A. Yap	4
5	Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C–Related Dilated Cardiomyopathy 2022 ·The American Journal of Cardiology ·Daniel P. Judge, Neal K. Lakdawala, Matthew R. Taylor, Luisa Mestroni, Hui‐Hua Li, Colleen Oliver, Franca S. Angeli, (unknown), Calum A. MacRae	14
6	Efficacy and Safety of ARRY-371797 in LMNA -Related Dilated Cardiomyopathy: A Phase 2 Study 2022 ·Circulation Genomic and Precision Medicine ·Calum A. MacRae, Matthew R.G. Taylor, Luisa Mestroni, (unknown), Euan A. Ashley, Matthew T. Wheeler, Neal K. Lakdawala, Ray E. Hershberger, Victor Sandor, M. Saunders, Colleen Oliver, Patrice A. Lee, Daniel P. Judge	12
7	Variation in Neonatal Nutrition Practice and Implications: A Survey of Australia and New Zealand Neonatal Units 2021 ·Frontiers in Nutrition ·(unknown), (unknown), (unknown), (unknown), Colleen Oliver, (unknown), Barbara E. Cormack	12
8	Abstract 12210: Long-Term Efficacy and Safety of ARRY-371797 (PF-0765803) in an Open-Label Rollover Study in Patients With Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation 2021 ·Circulation ·Daniel P. Judge, Neal K. Lakdawala, Matthew R.G. Taylor, Luisa Mestroni, Hui‐Hua Li, Colleen Oliver, Franca S. Angeli, Patrice A. Lee, Calum A. MacRae	2
9	Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors. 2021 ·Journal of Clinical Oncology ·Vivek Subbiah, Martin Gutierrez, Carey K. Anders, George Ansstas, Taofeek K. Owonikoko, Varun Monga, Peter Forsyth, Ibiayi Dagogo‐Jack, Sunandana Chandra, Katy K. Tsai, Eli L. Diamond, Meredith McKean, Elizabeth I. Buchbinder, (unknown), (unknown), Colleen Oliver, Micaela B. Reddy, Kati Maharry, Yan Xing	6
10	AAV6 as an effective gene delivery vector for prolonged transgene expression in intervertebral disc cells in vivo 2020 ·Genes & Diseases ·Chi Heon Kim, Colleen Oliver, Hamid Y. Dar, Hicham Drissi, Steven M. Presciutti	4
11	Do preterm girls need different nutrition to preterm boys? Sex-specific nutrition for the preterm infant 2020 ·Pediatric Research ·Anna C. Tottman, Colleen Oliver, Jane M. Alsweiler, Barbara E. Cormack	21
12	Neonatal dietitian resourcing and roles in New Zealand and Australia: A survey of current practice 2019 ·Nutrition & Dietetics ·Barbara E. Cormack, Colleen Oliver, (unknown), (unknown), (unknown), (unknown), (unknown), Helen Little, (unknown), (unknown)	6
13	Vitamin and Mineral Supplementation Practices in Preterm Infants: A Survey of Australian and New Zealand Neonatal Intensive and Special Care Units 2019 ·Nutrients ·Colleen Oliver, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Barbara E. Cormack	15
14	Omega-3 fatty acids for cystic fibrosis 2016 ·Cochrane Database of Systematic Reviews ·Colleen Oliver, Helen Watson	30
15	Lim Mineralization Protein-1 Knockout Mice Have Reduced Spine Trabecular Bone Density on Microcomputed Tomography due to Decreased Bone Morphogenetic Protein Responsiveness 2014 ·Neurosurgery ·(unknown), Manjula Viggeswarapu, Colleen Oliver, (unknown), Sreedhara Sangadala, Louisa Titus, Scott D. Boden	2
16	Omega-3 fatty acids for cystic fibrosis 2013 ·Cochrane Database of Systematic Reviews ·Colleen Oliver, Helen Watson	19
17	A Novel Low-Molecular-Weight Compound Enhances Ectopic Bone Formation and Fracture Repair 2013 ·Journal of Bone and Joint Surgery ·(unknown), Sreedhara Sangadala, Scott D. Boden, Katsuhito Yoshioka, William Hutton, Colleen Oliver, Louisa Titus	23
18	Recombinant Soluble Human FcγR1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis 2009 ·The Journal of Immunology ·Jeff L. Ellsworth, Nels Hamacher, Brandon Harder, (unknown), Thomas R. Bukowski, Kelly Byrnes-Blake, (unknown), Colleen Oliver, Kimberly S. Waggie, (unknown), (unknown), Mark W. Rixon, Katherine E. Lewis	25
19	Effect on bone induction of using contrast media to reconstitute recombinant human bone morphogenetic protein-2 in an ectopic model in rats 2006 ·Journal of Neurosurgery Spine ·(unknown), Colleen Oliver, (unknown), (unknown), Jeffrey M. Toth, Scott D. Boden	2
20	MECHANISM OF BONE FORMATION WITH GENE TRANSFER OF THE CDNA ENCODING FOR THE INTRACELLULAR PROTEIN LMP-1 2003 ·Journal of Bone and Joint Surgery ·Akihito Minamide, Scott D. Boden, Manjula Viggeswarapu, Gregory A. Hair, Colleen Oliver, Louisa Titus	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact